Under the Biden administration proposal unveiled last November, an estimated 3.4 million Americans on Medicare would be eligible in 2026 for the drugs, which carry a list price of more than $1,000 a month
In a phase 2 trial, VK2735 showed nearly 15% weight loss after 13 weeks, with up to 88% of participants achieving a weight loss of at least 10%
Our physician-led program is designed to help you lose weight safely and effectively with personalized care tailored to your health needs and goals
For NHS access, NICE then has to recommend it through a technology appraisal
So, we provide ongoing monitoring, adjustments to your treatment plan, and encouragement to keep you on the path toward weight loss
For patients struggling with weight, the difference between a medication that produces 15% weight loss versus one causing weight gain is transformative